VIRONOVATIVE BV

Patent Applications and Registrations

Patent applications and USPTO patent grants for VIRONOVATIVE BV.The latest application filed is for "virus causing respiratory tract illness in susceptible mammals".

Company Profile

1.7.6

VIRONOVATIVE BV - Rotterdam NL
ViroNovative B.V. - Rotterdam NL
ViroNovative B.V. - MedImmune Vaccines, Inc.
ViroNovative B.V. - Burgemeester Oudlaan 50 Rotterdam NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Virus causing respiratory tract illness in susceptible mammals Grant 10,519,517 - De Jong , et al. Dec	2019-12-31
Virus Causing Respiratory Tract Illness In Susceptible Mammals App 20160244850 - De Jong; Jan Cornelius ; et al.	2016-08-25
Virus Causing Respiratory Tract Illness in Susceptible Mammals App 20150093746 - De Jong; Jan Cornelius ; et al.	2015-04-02
Virus causing respiratory tract illness in susceptible mammals Grant 8,927,206 - De Jong , et al. January 6, 2	2015-01-06
Metapneumovirus Strains And Their Use In Vaccine Formulations And As Vectors For Expression Of Antigenic Sequences App 20140370497 - Fouchier; Ronaldus Adrianus Maria ; et al.	2014-12-18
Metapneumovirus Strains And Their Use In Vaccine Formulations And As Vectors For Expression Of Antigenic Sequences App 20140295409 - Fouchier; Ronaldus Adrianus Maria ; et al.	2014-10-02
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences Grant 8,841,433 - Fouchier , et al. September 23, 2	2014-09-23
Metapneumovirus strains and their use in vaccine formulations and sequences Grant 8,722,341 - Fouchier , et al. May 13, 2	2014-05-13
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus App 20100297730 - Fouchier; Ronaldus Adrianus Maria ; et al.	2010-11-25
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus Grant 7,704,720 - Tang , et al. April 27, 2	2010-04-27
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences Grant 7,531,342 - Fouchier , et al. May 12, 2	2009-05-12
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences Grant 7,449,324 - Fouchier , et al. November 11, 2	2008-11-11
Hmpv treatment with ribavirin and anti-hmpv antibody App 20070134255 - Maertzdorf; Jeroen ; et al.	2007-06-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.